Oyster Point Pharma Announces FDA Approval of TYRVAYA(TM) (varenicline solution) Nasal Spray for the Treatment of the Signs and Symptoms of Dry Eye Disease
TYRVAYA is the first and only nasal spray approved for the treatment of the signs and symptoms of dry eye disease TYRVAYA is designed to activate the trigeminal parasympathetic pathway resulting in increased production of basal tear film as a treatment ... Biopharmaceuticals, Ophthalmology, FDA Oyster Point Pharma, TYRVAYA, varenicline, dry eye disease (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 18, 2021 Category: Pharmaceuticals Source Type: news

Class 2 Medicines Recall: Pfizer Ltd, Champix (all strengths) film-coated tablets
Pfizer Ltd are recalling all in-date batches of Champix (varenicline) as a precautionary measure due to presence of levels of N-nitroso-varenicline above the acceptable level of intake. This recall al (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - October 14, 2021 Category: Drugs & Pharmacology Source Type: news

Combined treatments are the most effective to stop smoking, study finds
Combination therapies, particularly varenicline and nicotine replacement therapy (NRT) combined, are the most effective tobacco cessation pharmacotherapies, the largest review to examine the effectiveness and safety of electronic cigarettes (e-cigarettes) and medicines that people use to quit tobacco has found. (Source: University of Bristol news)
Source: University of Bristol news - October 12, 2021 Category: Universities & Medical Training Tags: Health, International, Research; Faculty of Health Sciences, Faculty of Health Sciences, Population Health Sciences, Institutes, Institutes, Bristol Population Health Science Institute; Press Release Source Type: news

Pfizer Recalls All Lots of Anti-Smoking Drug Chantix Due to Potential Carcinogen
Title: Pfizer Recalls All Lots of Anti-Smoking Drug Chantix Due to Potential CarcinogenCategory: Health NewsCreated: 9/17/2021 12:00:00 AMLast Editorial Review: 9/20/2021 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - September 20, 2021 Category: Respiratory Medicine Source Type: news

Pfizer Expands Voluntary Nationwide Recall to include Four Additional Lots of CHANTIX(R) (varenicline) Tablets Due to N- Nitroso Varenicline Content
NEW YORK, NY, Sept 19, 2021 -- Pfizer is voluntarily recalling an additional four lots of Chantix 0.5mg/1 mg Tablets to the patient (consumer/user) level due to the presence of a nitrosamine, N-nitroso-varenicline, above the Pfizer established Acceptable D... Biopharmaceuticals, FDA, Product Recall Pfizer, CHANTIX, varenicline (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 19, 2021 Category: Pharmaceuticals Source Type: news

Pfizer Recalls All Lots of Chantix Due to Potential Carcinogen
0.5 - mg and 1 - mg tablets may contain levels of N - nitroso - varenicline at or above levels approved by the FDA (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - September 18, 2021 Category: Psychiatry Tags: Family Medicine, Internal Medicine, Pharmacy, Psychiatry, Institutional, Source Type: news

Pfizer recalls anti-smoking drug due to high levels of ingredient tied increased risk of cancer
Pfizer recalled its anti-smoking drug Chantix due to high levels of an ingredient that is tied to an increased risk of cancer. (Source: Reuters: Health)
Source: Reuters: Health - September 18, 2021 Category: Consumer Health News Source Type: news

Pfizer recalls all lots of Chantix for high levels of nitrosamine, which can increase cancer risk
Pfizer is voluntarily recalling lots of its popular anti-smoking drug Chantix for high levels of nitrosamine, which can increase the... (Source: Reuters: Health)
Source: Reuters: Health - September 17, 2021 Category: Consumer Health News Source Type: news

Pfizer Expands Recall of Antismoking Drug to Include All Lots Pfizer Expands Recall of Antismoking Drug to Include All Lots
Ongoing concerns over a nitrosamine impurity in Chantix prompt Pfizer to recall all batches of the product in the United States as a precautionary measure.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - September 17, 2021 Category: Cancer & Oncology Tags: Psychiatry News Source Type: news

Pfizer Expands Voluntary Nationwide Recall to include All Lots of CHANTIX ® (Varenicline) Tablets Due to N-Nitroso Varenicline Content
Pfizer is voluntarily recalling all lots of Chantix 0.5 mg and 1 mg Tablets to the patient (consumer/user) level due to the presence of a nitrosamine, N-nitroso-varenicline, at or above the FDA interim acceptable intake limit. As alternative suppliers have been approved in the United States, Pfizer (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - September 17, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Pfizer Recalls Four More Lots of Smoking Cessation Drug Chantix Pfizer Recalls Four More Lots of Smoking Cessation Drug Chantix
Pfizer has voluntarily recalled four additional lots of varenicline (Chantix) because of the presence of a nitrosamine impurity, marking a recall total now of 16 lots.News Alerts (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 17, 2021 Category: Cancer & Oncology Tags: Psychiatry News Alert Source Type: news

Pfizer Expands Voluntary Nationwide Recall to include Four Additional Lots of CHANTIX ® (varenicline) Tablets Due to N- Nitroso Varenicline Content
Pfizer is voluntarily recalling an additional four lots of Chantix 0.5mg/1 mg Tablets to the patient (consumer/user) level due to the presence of a nitrosamine, N-nitroso-varenicline, above the Pfizer established Acceptable Daily Intake (ADI) level. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - August 16, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Pfizer Expands Recall of Smoking Cessation Drug Chantix Pfizer Expands Recall of Smoking Cessation Drug Chantix
The FDA says the health benefits of stopping smoking outweigh the cancer risk from the nitrosamine impurity potentially contained in the recalled varenicline lots.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 22, 2021 Category: Cancer & Oncology Tags: Psychiatry News Source Type: news

Pfizer Issues a Voluntary Nationwide Recall for Twelve Lots of CHANTIX ® (Varenicline) Tablets Due to N-Nitroso Varenicline Content
Pfizer is voluntarily recalling two lots of Chantix 0.5mg Tablets, two lots of Chantix 1 mg Tablets, and eight lots of a Chantix kit of 0.5mg/1 mg Tablets to the patient (consumer/user) level due to the presence of a nitrosamine, N-nitroso-varenicline, above the Pfizer established Acceptable Daily I (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - July 19, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA Allows Impure Smoking Cessation Drug to Stay on the Market FDA Allows Impure Smoking Cessation Drug to Stay on the Market
To ensure uninterrupted access to varenicline, the FDA will allow distribution of the smoking cessation drug to continue; some lots of pills were found to contain the carcinogen N-nitrosodimethylamine.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 19, 2021 Category: Consumer Health News Tags: Psychiatry News Source Type: news

FDA Updates and Press Announcements on Nitrosamine in Varenicline (Chantix)
FDA Updates and Press Announcements on Nitrosamine in in Varenicline (Chantix) (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - July 16, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Cytisine Not Noninferior to Varenicline for Smoking Cessation
Significantly fewer adverse reactions reported by those in the cytisine group versus the varenicline group (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - July 8, 2021 Category: Psychiatry Tags: Family Medicine, Internal Medicine, Pharmacy, Psychiatry, Journal, Source Type: news

Cytisine Not Noninferior to Varenicline for Smoking Cessation
THURSDAY, July 8, 2021 -- Cytisine treatment fails to demonstrate noninferiority to varenicline treatment for smoking cessation, according to a study published in the July 6 issue of the Journal of the American Medical Association. Ryan J.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 8, 2021 Category: Pharmaceuticals Source Type: news

Pfizer suspends distribution of anti-smoking drug after cancer-causing agents found in the pills
(Natural News) On Thursday, June 24, Pfizer announced it is temporarily halting the distribution of its anti-smoking pill, Chantix. The company is doing this after it found heightened levels of a cancer-causing compound in the drug. Chantix was approved by the Food and Drug Administration (FDA) in May 2006 as a prescription medication that is supposed to help... (Source: NaturalNews.com)
Source: NaturalNews.com - June 27, 2021 Category: Consumer Health News Source Type: news

Pfizer Pauses Distribution of Stop-Smoking Pill Chantix Pfizer Pauses Distribution of Stop-Smoking Pill Chantix
Pfizer told Reuters the distribution pause was ordered out of an abundance of caution while further testing is conducted. FDA approved varenicline, marketed as Chantix, in 2006.WebMD Health News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - June 25, 2021 Category: Drugs & Pharmacology Tags: Pulmonary Medicine News Alert Source Type: news

Medication may help heavy-drinking smokers improve their health
This study confirms that medications can play a role, Ray said, but she noted that it can be challenging for patients to take more than one prescribed medication.“Varenicline alone is doing a great job, and this trial indicates that there is not much room for naltrexone to make a difference,” Ray said. “But even medications like varenicline have their limitations. Medication is only part of the solution. There remains much research to be done on addict ions and how to treat them.”Ray says that those who wish to quit smoking and reduce drinking may consider talking to their doctor about the possibili...
Source: UCLA Newsroom: Health Sciences - June 15, 2021 Category: Universities & Medical Training Source Type: news

Varenicline Nasal Spray Efficacious for Dry Eye Varenicline Nasal Spray Efficacious for Dry Eye
Nasal spray reduces signs and symptoms of dry eye disease in phase 3 trial.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 7, 2021 Category: Consumer Health News Tags: Ophthalmology News Source Type: news

Sharing Mayo Clinic: Daughter quits smoking to donate liver to her mom
When she learned that a liver transplant could save her mom's life, April Wilson didn't hesitate to stop smoking and say yes to being a living donor. April Wilson smoked for 25 years and tried many times to quit, but nothing seemed to work. "I tried everything," April says. "I used every replacement therapy, Chantix, [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 4, 2021 Category: Databases & Libraries Source Type: news

Starting smoking cessation in hospitalized patients would reduce many premature deaths
(Florida Atlantic University) Each year in the U.S., about 30 million hospitalizations occur in individuals 18 and older. Of these, more than 7 million are current cigarette smokers whose average hospital stay is several days. Researchers say that starting smoking cessation therapy during hospitalization and maintaining high adherence post-discharge can markedly improve permanent quit rates in these patients with minimal to no side effects. Cessation therapy also should include long-term counseling and at least 90 days of a prescription drug, specifically, varenicline. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 25, 2021 Category: Cancer & Oncology Source Type: news

Oyster Point Pharma Announces FDA Acceptance for Filing New Drug Application for OC-01 (varenicline) Nasal Spray for the Treatment of Signs and Symptoms of Dry Eye Disease
PRINCETON, N.J., March 02, 2021 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. (Nasdaq: OYST), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - March 2, 2021 Category: Drugs & Pharmacology Source Type: news

Comunicado de la FDA sobre la seguridad de los medicamentos: Actualizaci ón del estudio de seguridad sobre Chantix (vareniclina) y el riesgo de sucesos cardiovasculares adversos
El 12 de diciembre, 2012, La Administraci ón de Alimentos y Medicamentos de Estados Unidos (FDA por sus siglas en inglés) le informó al público sobre los resultados de un extenso análisis combinado (denominado metanálisis) de estudios clínicos que compararon a pacientes que recibieron el medicamento para dejar de fumar Chantix (vare niclina) con pacientes que recibieron un placebo (un tratamiento inactivo). (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - December 23, 2020 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Varenicline Strongly Recommended for Smoking Cessation
Guideline offers simple practice changes that may increase effectiveness of tobacco - dependence pharmacotherapy (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - July 23, 2020 Category: Respiratory Medicine Tags: Cardiology, Endocrinology, Family Medicine, Internal Medicine, Oncology, Pharmacy, Psychiatry, Pulmonology, Journal, Source Type: news

Varenicline Strongly Recommended for Smoking Cessation
THURSDAY, July 23, 2020 -- Varenicline is strongly recommended over the patch for adult smokers hoping to quit, according to an American Thoracic Society practice guideline published online in the July 15 issue of the American Journal of Respiratory... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 23, 2020 Category: Pharmaceuticals Source Type: news

Relapse prevention interventions for smoking cessation
Updated review found that behavioural interventions provided no worthwhile benefit in preventing relapse in assisted abstainers. Moderate certainty evidence suggests that extended treatment with varenicline but not bupropion helped to prevent relapse. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - July 21, 2020 Category: Consumer Health News Source Type: news

Experts strongly recommend varenicline over the patch for adult smokers hoping to quit
(American Thoracic Society) Smoking cessation initiatives notwithstanding, along with provocative public health campaigns and clinical guidance, quitting tobacco has remained elusive for many smokers. The American Thoracic Society's new clinical practice guideline on treatment for tobacco dependence in adults addresses how clinicians may deal with patients' reluctance to quit, one of a number of issues not previously assessed in the older guidelines. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 15, 2020 Category: International Medicine & Public Health Source Type: news

Safety of varenicline as an aid to smoking cessation in professional drivers and its impact on driving behaviors: an observational cohort study of taxi drivers in Beijing - Chu S, Liang L, Jing H, Zhang D, Tong Z.
INTRODUCTION: Varenicline is an effective smoking cessation medicine. However, the possible adverse neuropsychiatric events reported by Food and Drug Administration for varenicline may cause safety problems for professional drivers. We aimed to investigate... (Source: SafetyLit)
Source: SafetyLit - June 10, 2020 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

UniSA research uncovers treatment combo that sees smokers six times more likely to quit
(University of South Australia) New research led by the University of South Australia has found that smokers who receive the medication varenicline tartrate combined with Quitline counselling following a period of hospitalisation due to a tobacco-related illness are six times more likely to quit smoking than those who attempt to stop without support. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - May 1, 2020 Category: International Medicine & Public Health Source Type: news

Varenicline Seems Safe for Adults Without Depression
Risk for CV, neuropsychiatric hospitalizations lower for varenicline versus nicotine replacement therapy (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - February 28, 2020 Category: Psychiatry Tags: Cardiology, Family Medicine, Internal Medicine, Neurology, Pharmacy, Psychiatry, Journal, Source Type: news

Varenicline Seems Safe for Adults Without Depression
FRIDAY, Feb. 28, 2020 -- For adults without a recent history of depression, use of varenicline for smoking cessation does not appear to be associated with an increased risk for cardiovascular (CV) or neuropsychiatric hospitalizations when compared... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 28, 2020 Category: Pharmaceuticals Source Type: news

New study supports the safety of varenicline
(Society for the Study of Addiction) A real-world study of over 600,000 adult participants without a history of depression has found that the stop-smoking medication varenicline (marketed as Chantix and Champix) does not appear to be associated with an increased risk of cardiovascular or neuropsychiatric hospitalization compared with nicotine replacement therapy (NRT). These findings confirm those of earlier clinical trials, providing further evidence of the safety of varenicline as an aid to stop smoking. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - February 20, 2020 Category: International Medicine & Public Health Source Type: news

Podcast: Can people stop smoking by cutting down the amount they smoke first?
There are more than 50 Cochrane Reviews of the effects of interventions to help people quit smoking; one of which investigates whether reducing smoking before quitting might be an alternative to stopping suddenly. It was updated in September 2019 and we asked lead author, Nicola Lindson, from the Cochrane Tobacco Addiction Group based in the University of Oxford in the UK to tell us about their latest findings.The standard way that people are told to quit smoking is to smoke as normal until a quit day, and then stop using all cigarettes. However, this is daunting for many, and those who have tried it without success might ...
Source: Cochrane News and Events - January 2, 2020 Category: Information Technology Authors: Lydia Parsonson Source Type: news

Smoking cessation treatment targets adolescents
This study found that while there was no significant difference between the varenicline group and the placebo group at end of treatment, those in the varenicline group quit earlier in the trial and were less likely to relapse after the trial was over. And it encourages new treatments designs for adolescents. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 10, 2019 Category: International Medicine & Public Health Source Type: news

Featured Review: Can people stop smoking by cutting down the amount they smoke first?
This Cochrane Review looks at whether cutting down before quitting helps people to stop smoking, and the best ways that people can cut down to help them stop completely, the study included 51 studies of over 22,000 people who smoked tobacco.Nicola Lindson, lead author of this Cochrane review explains, “The standard way people are told to quit smoking is to smoke as normal until a quit day, when they stop using all cigarettes. However, many have tried this before and been unsuccessful, and might like to try something new.”“Some people prefer to cut down the number of cigarettes they smoke before quitting c...
Source: Cochrane News and Events - October 3, 2019 Category: Information Technology Authors: Katie Abbotts Source Type: news

varenicline (Chantix)
Title: varenicline (Chantix)Category: MedicationsCreated: 2/28/2008 12:00:00 AMLast Editorial Review: 8/14/2019 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - August 14, 2019 Category: Respiratory Medicine Source Type: news

FDA Drug Safety Communication: Chantix (varenicline) drug label now contains updated efficacy and safety information
[7-22-2011] The U.S. Food and Drug Administration (FDA) has approved an updated drug label for the smoking cessation aid Chantix (varenicline) to include information about the efficacy and safety of the drug in two patient populations who may benefit greatly from giving up smoking �those with cardiovascular disease and those with chronic obstructive pulmonary disease (COPD). (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 28, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA Drug Safety Communication: Safety review update of Chantix (varenicline) and risk of neuropsychiatric adverse events
[10-24-2011] The U.S. Food and Drug Administration (FDA) has reviewed the results from two FDA-sponsored epidemiological studies that evaluated the risk of neuropsychiatric adverse events associated with the smoking cessation drug Chantix (varenicline). (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 28, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Ultrapotent chemogenetics for research and potential clinical applications
Chemogenetics enables noninvasive chemical control over cell populations in behaving animals. However, existing small-molecule agonists show insufficient potency or selectivity. There is also a need for chemogenetic systems compatible with both research and human therapeutic applications. We developed a new ion channel–based platform for cell activation and silencing that is controlled by low doses of the smoking cessation drug varenicline. We then synthesized subnanomolar-potency agonists, called uPSEMs, with high selectivity for the chemogenetic receptors. uPSEMs and their receptors were characterized in brains of ...
Source: ScienceNOW - April 10, 2019 Category: Science Authors: Magnus, C. J., Lee, P. H., Bonaventura, J., Zemla, R., Gomez, J. L., Ramirez, M. H., Hu, X., Galvan, A., Basu, J., Michaelides, M., Sternson, S. M. Tags: Neuroscience, Online Only, Techniques r-articles Source Type: news

Big rise in crack use
Availability, production and purity of the drug is rising across England Related items fromOnMedica NI drug deaths in males double in a decade Philip Morris knew nicotine is just one part of smoking addiction Prescribe higher dose opioids for shorter time after surgery Start varenicline sooner to boost success NHS changes must not affect drug safety (Source: OnMedica Latest News)
Source: OnMedica Latest News - March 24, 2019 Category: UK Health Source Type: news

Smoking During Pregnancy Doubles Risk Of Sudden Death For Baby, Study Says
(CNN) — Smoking even one cigarette a day during pregnancy can double the chance of sudden unexpected death for your baby, according to a new study analyzing over 20 million births, including over 19,000 unexpected infant deaths. The study, published Monday in the journal Pediatrics, analyzed data on smoking during pregnancy from the US Centers for Disease Control and Prevention’s birth/infant death data set between 2007 and 2011 and found that the risk of death rises by .07 for each additional cigarette smoked, up to 20 a day, a typical pack of cigarettes. By the time you smoke a pack a day, the study found, yo...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - March 11, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Cigarettes Pregnancy Smoking Source Type: news

Smoking Cessation Drug Not for Kids, FDA Says Smoking Cessation Drug Not for Kids, FDA Says
The FDA has ruled the smoking cessation drug varenicline (Chantix) should not be used in patients younger than 16 because of a lack of efficacy.News Alerts (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 25, 2019 Category: Consumer Health News Tags: Psychiatry News Alert Source Type: news

Smokers With Cancer May Benefit From Longer Cessation Tx
(MedPage Today) -- Trial showed 24 weeks of Chantix led to better quit rates than 12 weeks of therapy (Source: MedPage Today Pulmonary)
Source: MedPage Today Pulmonary - January 28, 2019 Category: Respiratory Medicine Source Type: news

Cancer patients can quit smoking through lengthened medication time, counseling support
(Northwestern University) More than 50 percent of cancer patients still smoke after being diagnosed, yet quitting smoking can significantly improve the effectiveness of cancer treatment. A new study from Northwestern Medicine and the Abramson Cancer Center at the University of Pennsylvania found cancer patients have better success quitting and are not as prone to relapsing one year later if they undergo counseling sessions for 24 weeks and take the smoking cessation medication   varenicline (e.g. Chantix)   for 24 weeks, compared to the routine 12 weeks. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 25, 2019 Category: Cancer & Oncology Source Type: news

Quit-smoking drug helps addicts ditch the habit without any withdrawals
Scientists from Scripps Research Institute plan to investigate the effects of NicA2-J1 in human smokers and hope to test whether the drug Chantix also blocks nicotine from reaching rats' brains. (Source: the Mail online | Health)
Source: the Mail online | Health - October 18, 2018 Category: Consumer Health News Source Type: news

Funding cuts lead to dramatic fall in prescribing of stop smoking products
The number of prescriptions issued in primary care in England for nicotine replacement therapy (NRT) fell by 75% between 2005/6 and 2016/17 and dispensing rates for varenicline fell by more than 50% between 2010/11 and 2016/17, according to new analysis. (Source: GP Online News)
Source: GP Online News - July 15, 2018 Category: Primary Care Tags: Smoking cessation Source Type: news

No Heart Risk From Stop-Smoking Drugs Chantix and Zyban: Study
Title: No Heart Risk From Stop-Smoking Drugs Chantix and Zyban: StudyCategory: Health NewsCreated: 4/10/2018 12:00:00 AMLast Editorial Review: 4/11/2018 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - April 11, 2018 Category: Cardiology Source Type: news